|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.18 USD | -0.32% |
|
+1.73% | -2.12% |
| May. 09 | HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance | MT |
| May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
April 13 (Reuters) -
* PFIZER SAYS CO HAS CONDUCTED A COMPREHENSIVE ASSESSMENT OF ONGOING AGGREGATE SAFETY DATA FOR ITS VACCINE- TWEET
* PFIZER SAYS FOUND NO EVIDENCE TO CONCLUDE THAT ARTERIAL OR VENOUS THROMBOEMBOLIC EVENTS ARE A RISK ASSOCIATED WITH THE USE OF CO’S COVID VACCINE Source text: https://bit.ly/3g9zIdw
| 1st Jan change | Capi. | |
|---|---|---|
| -2.12% | 160B | |
| +32.36% | 695B | |
| +26.51% | 568B | |
| -4.40% | 361B | |
| +19.46% | 330B | |
| +3.50% | 283B | |
| +17.00% | 239B | |
| +7.95% | 204B | |
| -7.57% | 198B | |
| +8.62% | 168B |
PFIZER, INC. 
